Reviews

Application and research progress of light therapy in bipolar disorder

  • LI Ping ,
  • MA Yantao
Expand
  • 1. Shijiazhuang Eighth Hospital, Shijiazhuang 050081, China;
    2. Peking University Sixth Hospital, Beijing 100191, China

Received date: 2023-12-03

  Revised date: 2024-04-29

  Online published: 2024-10-17

Abstract

Bipolar disorder (BD) is the most dangerous mental illness, with the highest suicide rate among various mental illnesses. Light therapy (LT) is a novel and effective therapy for BD. In this article, the physiological mechanisms and current clinical applications of LT in the treatment of BD are reviewed. LT transmits light signals through the inherent photosensitive retinal ganglion cells on the retina to areas such as the anterior chiasmatic nucleus of the hypothalamus, promoting their regulatory functions concerning circadian rhythm, endocrine, and neurotransmitters, thereby relieving BD depression. The mainstream view is that both single LT and LT combination therapy can significantly reduce the severity of depression in BD. With good safety of LT treatment for BD, both strong and weak light treatments are suitable for BD patients. Currently, research mainly adopts white light treatment, with a course of 1~8 weeks. Further research on LT clinical parameters (such as intensity, spectrum, and daily exposure duration) is still needed to provide reference for clinical practice.

Cite this article

LI Ping , MA Yantao . Application and research progress of light therapy in bipolar disorder[J]. Science & Technology Review, 2024 , 42(18) : 91 -97 . DOI: 10.3981/j.issn.1000-7857.2024.04.00323

References

[1] Grande I, Berk M, Birmaher B, et al. Bipolar disorder[J]. The Lancet, 2016, 387(10027): 1561-1572.
[2] Huang Y Q, Wang Y, Wang H, et al. Prevalence of mental disorders in China: A cross-sectional epidemiological study[J]. The Lancet Psychiatry, 2019, 6(3): 211-224.
[3] Judd L L, Akiskal H S, Schettler P J, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder[J]. Archives of General Psychiatry, 2003, 60(3): 261.
[4] Benedetti F. Rate of switch from bipolar depression into mania after morning light therapy: A historical review[J]. Psychiatry Research, 2018, 261: 351-356.
[5] Köhler S, Gaus S, Bschor T. The challenge of treatment in bipolar depression: Evidence from clinical guidelines, treatment recommendations and complex treatment situations[J]. Pharmacopsychiatry, 2014, 47(2): 53-59.
[6] Lam R W, Levitt A J, Levitan R D, et al. Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder[J]. JAMA Psychiatry, 2016, 73(1): 56.
[7] Sit D, Wisner K L, Hanusa B H, et al. Light therapy for bipolar disorder: A case series in women[J]. Bipolar Disorders, 2007, 9(8): 918-927.
[8] Benedetti F, Colombo C. Sleep deprivation in mood disorders[J]. Neuropsychobiology, 2011, 64(3): 141-151.
[9] Leverich G S, Altshuler L L, Frye M A, et al. Risk of switch in mood polarity to hypomania or Mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers[J]. American Journal of Psychiatry, 2006, 163(2): 232-239.
[10] Etain B. Circadian abnormalities as markers of susceptibility in bipolar disorders[J]. Frontiers in Bioscience, 2014, S6(1): 120-137.
[11] Valenzuela F J, Vera J, Venegas C, et al. Evidences of polymorphism associated with circadian system and risk of pathologies: A review of the literature[J]. International Journal of Endocrinology, 2016, 2016: 2746909.
[12] Hasler G, Drevets W C, Gould T D, et al. Toward constructing an endophenotype strategy for bipolar disorders [J]. Biological Psychiatry, 2006, 60(2): 93-105.
[13] Martiny K, Volf C, Svendsen S D, et al. Psychiatry and circadian rhythms[J]. Ugeskrift for Laeger, 2018, 180(36): V04180278.
[14] Jermann F, Richard-Lepouriel H, Aubry J M. Lightdarkness and bipolar disorder[J]. Revue Medicale Suisse, 2020, 16(707): 1745-1747.
[15] Tseng P T, Chen Y W, Tu K Y, et al. Light therapy in the treatment of patients with bipolar depression: A meta-analytic study[J]. European Neuropsychopharmacology, 2016, 26(6): 1037-1047.
[16] Albrecht U. Circadian clocks and mood-related behaviors[J]. Handbook of Experimental Pharmacology, 2013(217): 227-239.
[17] Çalıyurt O. Role of chronobiology as a transdisciplinary field of research: Its applications in treating mood disorders[J]. Balkan Medical Journal, 2017, 34(6): 514-521.
[18] von Gall C. The effects of light and the circadian system on rhythmic brain function[J]. International Journal of Molecular Sciences, 2022, 23(5): 2778.
[19] Maynard M L, Zele A J, Kwan A S, et al. Intrinsically photosensitive retinal ganglion cell function, sleep efficiency and depression in advanced age-related macular degeneration[J]. Investigative Opthalmology & Visual Science, 2017, 58(2): 990.
[20] 方靓, 秦曦明, 朱道民. 双相情感障碍与生物节律相关生物机制研究进展[J]. 精神医学杂志, 2022, 35(1): 94-98.
[21] Bumb J M, Enning F, Mueller J K, et al. Differential melatonin alterations in cerebrospinal fluid and serum of patients with major depressive disorder and bipolar disorder[J]. Comprehensive Psychiatry, 2016, 68: 34-39.
[22] Bouwmans M E J, Bos E H, Booij S H, et al. Intra-and inter-individual variability of longitudinal daytime melatonin secretion patterns in depressed and non-depressed individuals[J]. Chronobiology International, 2015, 32(3): 441-446.
[23] Fang L, Yu Q M, Yin F F, et al. Combined cortisol and melatonin measurements with detailed parameter analysis can assess the circadian rhythms in bipolar disorder patients[J]. Brain and Behavior, 2021, 11(7): e2186.
[24] Valdés-Tovar M, Estrada-Reyes R, Solís-Chagoyán H, et al. Circadian modulation of neuroplasticity by melatonin: A target in the treatment of depression[J]. British Journal of Pharmacology, 2018, 175(16): 3200-3208.
[25] 杨丽, 任若佳, 王学义. 光照治疗抑郁症现状及其相关机制研究进展[J]. 中国神经精神疾病杂志, 2021, 47(11): 698-701.
[26] Barclay N L, Eley T C, Buysse D J, et al. Diurnal preference and sleep quality: Same genes? A study of young adult twins[J]. Chronobiology International, 2010, 27(2): 278-296.
[27] Huang M C, Chuang S C, Tseng M C M, et al. Cortisol awakening response in patients with bipolar disorder during acute episodes and partial remission: A pilot study[J]. Psychiatry Research, 2017, 258: 594-597.
[28] Minnetti M, Hasenmajer V, Pofi R, et al. Fixing the broken clock in adrenal disorders: Focus on glucocorticoids and chronotherapy[J]. Journal of Endocrinology, 2020, 246(2): R13-R31.
[29] Adamsson M, Laike T, Morita T. Annual variation in daily light exposure and circadian change of melatonin and cortisol concentrations at a northern latitude with large seasonal differences in photoperiod length[J]. Journal of Physiological Anthropology, 2016, 36(1): 6.
[30] Tyrer A E, Levitan R D, Houle S, et al. Serotonin transporter binding is reduced in seasonal affective disorder following light therapy[J]. Acta Psychiatrica Scandinavica, 2016, 134(5): 410-419.
[31] Sit D, Haigh S. Use of "lights" for bipolar depression[J]. Current Psychiatry Reports, 2019, 21(6): 45.
[32] 刘东歌, 肖晶晶, 刘宇昊, 等. 不同强度光照对双相抑郁患者疗效比较的随机对照研究[J]. 临床精神医学杂志, 2022, 32(5): 362-365.
[33] Clark C T, Wisner K L. Treatment of peripartum bipolar disorder[J]. Obstetrics and Gynecology Clinics of North America, 2018, 45(3): 403-417.
[34] Wirz-Justice A, Terman M. CME: Light therapy: Why, what, for whom, how, and when (and a postscript about darkness)[J]. Praxis, 2022, 111(2): 56-62.
[35] Wen J H, Sawmiller D, Wheeldon B, et al. A review for lithium: Pharmacokinetics, drug design, and toxicity[J]. CNS & Neurological Disorders-Drug Targets, 2020, 18(10): 769-778.
[36] DeVane C L. Pharmacokinetics, drug interactions, and tolerability of valproate[J]. Psychopharmacology Bulletin, 2003, 37(Suppl 2): 25-42.
[37] Geoffroy P A, Schroder C M, Bourgin P. Light treatment in depression: An Antique treatment with new insights [J]. Sleep Medicine Reviews, 2018, 40: 218-219.
[38] Takeshima M, Utsumi T, Aoki Y, et al. Efficacy and safety of bright light therapy for manic and depressive symptoms in patients with bipolar disorder: A systematic review and meta-analysis[J]. Psychiatry and Clinical Neurosciences, 2020, 74(4): 247-256.
[39] Hirakawa H, Terao T, Muronaga M, et al. Adjunctive bright light therapy for treating bipolar depression: A systematic review and meta-analysis of randomized controlled trials[J]. Brain and Behavior, 2020, 10(12): e1876.
[40] Yatham L N, Kennedy S H, Parikh S V, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder[J]. Bipolar Disorders, 2018, 20(2): 97-170.
[41] Dauphinais D R, Rosenthal J Z, Terman M, et al. Controlled trial of safety and efficacy of bright light therapy vs. negative air ions in patients with bipolar depression [J]. Psychiatry Research, 2012, 196(1): 57-61.
[42] Benedetti F, Riccaboni R, Locatelli C, et al. Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression[J]. The Journal of Clinical Psychiatry, 2014, 75(2): 133-140.
[43] Wang S J, Zhang Z G, Yao L, et al. Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis[J]. PLoS One, 2020, 15(5): e0232798.
[44] 任若佳, 卢文婷, 高媛媛, 等. 室内光照辅助治疗抑郁症的疗效与安全性研究[J]. 中国神经精神疾病杂志, 2023, 49(12): 720-726.
[45] Maruani J, Geoffroy P A. Bright light as a personalized precision treatment of mood disorders[J]. Frontiers in Psychiatry, 2019, 10: 85.
[46] Sit D K, McGowan J, Wiltrout C, et al. Adjunctive bright light therapy for bipolar depression: A randomized double-blind placebo-controlled trial[J]. American Journal of Psychiatry, 2018, 175(2): 131-139.
[47] Zhou T H, Dang W M, Ma Y T, et al. Clinical efficacy, onset time and safety of bright light therapy in acute bipolar depression as an adjunctive therapy: A randomized controlled trial[J]. Journal of Affective Disorders, 2018, 227: 90-96.
[48] Do A, Li V W, Huang S, et al. Blue-light therapy for seasonal and non-seasonal depression: A systematic review and meta-analysis of randomized controlled trials [J]. The Canadian Journal of Psychiatry, 2022, 67(10): 745-754.
[49] 潘蓉, 廖继武, 潘集阳. 光照治疗抑郁发作的研究进展[J]. 临床精神医学杂志, 2022, 32(3): 249-252.
Outlines

/